Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance - ScienceDirect

Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance - ScienceDirect

Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells - ScienceDirect

Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement - ScienceDirect

Lactylation-driven METTL3-mediated RNA m6A modification promotes immunosuppression of tumor-infiltrating myeloid cells - ScienceDirect

The Emerging Hallmarks of Cancer Metabolism - ScienceDirect

FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis - ScienceDirect

Cancers, Free Full-Text

The potential role of RNA modification in skin diseases, as well as the recent advances in its detection methods and therapeutic agents - ScienceDirect

Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance - ScienceDirect

FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis - ScienceDirect

Intermediary metabolism: An intricate network at the crossroads of cell fate and function - ScienceDirect

N6-methyladenosine-mediated gene regulation and therapeutic implications: Trends in Molecular Medicine

Advances in targeting RNA modifications for anticancer therapy: Trends in Cancer